Captrust Financial Advisors Lannett CO Inc Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.75 - $1.77 $520 - $1,228	-694 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.93 $39 - $73	-25 Reduced 3.48%	694 $1,000
Q3 2021 Nov 16, 2021	SELL	$2.91 - $4.83 $2,304 - $3,825	-792 Reduced 52.42%	719 $2,000
Q2 2021 Aug 16, 2021	SELL	$4.17 - $5.74 $7,939 - $10,928	-1,904 Reduced 55.75%	1,511 $7,000
Q1 2021 May 17, 2021	BUY	$5.28 - $9.64 $17,661 - $32,245	3,345 Added 4778.57%	3,415 $18,000
Q4 2020 Feb 16, 2021	BUY	$5.75 - $7.13 $402 - $499	70 New	70 $0

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.